Literature DB >> 10954280

Change of spontaneous reaction of glue and lipiodol mixture during embolization after the addition of tungsten powder: in vitro study.

D C Suh1, H B Shi, S S Park, M S Lee, H Y Choi.   

Abstract

BACKGROUND AND
PURPOSE: We have noted that glue-Lipiodol mixtures harden prematurely in the catheter during embolization of brain arteriovenous malformations. However, we observed that hardening of this embolic material does not occur when tungsten powder is added to the glue mixture. In order to clarify the effect of tungsten powder on the glue mixture, we evaluated the reaction time and hardness of the glue mixture in vitro after the addition of tungsten powder. We also measured the pH of the tungsten solution.
METHODS: Six lots of Lipiodol and three lots of Histoacryl Blue were mixed in a 5-cc bottle with a 50% to 25% glue concentration (glue:Lipiodol = 1:1 to 1:3) and this mixture was observed for 2 weeks. The hardness of the polymerized glue mixture was categorized as liquid, gel, semi-solid, or solid. Various series of experiments were performed after the addition of tungsten powder (0.2 g) and blood (a drop) into the glue mixture. We also separately mixed tungsten and tantalum powder in tubes, each with 5 mL of distilled water, and then measured the pH of these three times. The mixed amounts of tungsten and tantalum ranged from 0.1 to 0.5 mg.
RESULTS: In a 50% glue concentration, the glue mixture turned into a solid cast within 48 hours. In a 25% concentration, the glue mixture turned into gel within 24 hours. The casts became solid in the 50% and gelled in the 25% concentration, and solid or gel in 28% and 33% glue mixture concentrations. The addition of tungsten powder to 50% and 25% glue mixture concentrations caused the glue mixtures to remain in a liquid state for 2 weeks regardless of the Lipiodol products used. Measurement of acidity achieved using a pH meter in 5 cc of distilled water with tungsten powder (0.1 to 0.5 g) revealed a change of pH from 3.5 to 2.6 according to the amount of tungsten added. Tantalum revealed weak acidity, with a pH range from 6.4 to 5.7. The addition of blood immediately caused the mixture to become solid in 50% and semi-solid in 25% glue concentrations.
CONCLUSION: The reaction time of the glue mixture differed according to the lot number of the Lipiodol. The addition of tungsten powder appeared to prevent premature cast formation by decreasing the pH with a mechanism similar to that of adding acetic acid.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10954280      PMCID: PMC8174906     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  6 in total

1.  Letter to the editor. Early polymerisation of histoacryl mixed with lipiodol.

Authors:  R van den Berg; L S Kool; M van Dijk; M A van Buchem
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

2.  Penetration Difference of n-Butyl2-Cyanoacrylate into the Nidus in the Embolisation of Brain Arteriovenous Malformation.

Authors:  D C Suh; J H Kim; M S Lee; S Park; S T Kim; C G Choi; H K Lee; C J Kim; H Y Song
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

3.  Adjusting the polymerization time of isobutyl-2 cyanoacrylate.

Authors:  S M Spiegel; F Viñuela; J M Goldwasser; A J Fox; D M Pelz
Journal:  AJNR Am J Neuroradiol       Date:  1986 Jan-Feb       Impact factor: 3.825

4.  Spontaneous polymerisation of cyanoacrylate/lipiodol mixtures causing failed embolisation. Laboratory studies.

Authors:  H T Apsimon; A Bartlett; R Phadke; M S Khangure
Journal:  Interv Neuroradiol       Date:  2001-05-15       Impact factor: 1.610

5.  n-Butyl 2-cyanoacrylate--substitute for IBCA in interventional neuroradiology: histopathologic and polymerization time studies.

Authors:  M F Brothers; J C Kaufmann; A J Fox; J P Deveikis
Journal:  AJNR Am J Neuroradiol       Date:  1989 Jul-Aug       Impact factor: 3.825

6.  Modification of cyanoacrylate for therapeutic embolization: preliminary experience.

Authors:  L D Cromwell; C W Kerber
Journal:  AJR Am J Roentgenol       Date:  1979-05       Impact factor: 3.959

  6 in total
  6 in total

1.  International survey on neuroradiological interventional and therapeutic devices and materials.

Authors:  René van den Berg; Thomas E Mayer
Journal:  Interv Neuroradiol       Date:  2015-10-13       Impact factor: 1.610

2.  A nonadhesive liquid embolic agent of ethylene vinyl alcohol copolymer and ethanol mixture for cerebral arteriovenous malformations. Clinical experience.

Authors:  J I Hamada; Y Kai; T Mizuno; M Morioka; K Kazekawa; H Iwata; Y Ushio
Journal:  Interv Neuroradiol       Date:  2008-06-09       Impact factor: 1.610

3.  Percutaneous direct puncture glue embolization of high-flow craniofacial arteriovenous lesions: a new circular ring compression device with a beveled edge.

Authors:  C W Ryu; S M Whang; D C Suh; S-M Kim; Y-J Jang; H-J Kim; M-J Kim; S E Chang; J P Hong; S J Kim
Journal:  AJNR Am J Neuroradiol       Date:  2007-03       Impact factor: 3.825

4.  Cyst ablation using a mixture of N-butyl cyanoacrylate and iodized oil in patients with autosomal dominant polycystic kidney disease: the long-term results.

Authors:  See Hyung Kim; Seung Hyup Kim; Jeong Yeon Cho
Journal:  Korean J Radiol       Date:  2009-06-25       Impact factor: 3.500

5.  Guidelines for the use of NBCA in vascular embolization devised by the Committee of Practice Guidelines of the Japanese Society of Interventional Radiology (CGJSIR), 2012 edition.

Authors:  Yoshito Takeuchi; Hiroyuki Morishita; Yozo Sato; Shingo Hamaguchi; Noriaki Sakamoto; Hiroyuki Tokue; Takafumi Yonemitsu; Kenji Murakami; Hiroyasu Fujiwara; Keitaro Sofue; Toshi Abe; Hideyuki Higashihara; Yasuo Nakajima; Morio Sato
Journal:  Jpn J Radiol       Date:  2014-06-03       Impact factor: 2.374

6.  Effect of glacial acetic acid and ethiodized oil concentration on embolization with N-butyl 2-cyanoacrylate: an in vivo investigation.

Authors:  Matthew J Gounis; Baruch B Lieber; Ajay K Wakhloo; Ralf Siekmann; L N Hopkins
Journal:  AJNR Am J Neuroradiol       Date:  2002 Jun-Jul       Impact factor: 3.825

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.